Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Ethosuximide
Drug ID BADD_D00846
Description An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Indications and Usage For the treatment of petit mal epilepsy.
Marketing Status approved
ATC Code N03AD01
DrugBank ID DB00593
KEGG ID D00539
MeSH ID D005013
PubChem ID 3291
TTD Drug ID D0Q4XQ
NDC Product Code 65655-0001; 0071-2418; 61748-025; 49452-2803; 0121-0670; 17349-0006; 59762-2250; 63629-8005; 59762-2350; 23155-532; 0071-0237; 42806-708; 64380-878; 69452-152; 11014-0047; 51927-3436; 42806-711; 10888-8169
UNII 5SEH9X1D1D
Synonyms Ethosuximide | Ethosuccimid | Ethylmethylsuccimide | Ethymal | Zarontin | Petnidan | Pyknolepsinum | Suksilep | Suxilep | Emeside | Etosuximida Faes | Faes, Etosuximida
Chemical Information
Molecular Formula C7H11NO2
CAS Registry Number 77-67-8
SMILES CCC1(CC(=O)NC1=O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Urinary tract disorder20.08.01.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Vomiting07.01.07.0030.039300%
Weight decreased13.15.01.005--
Lupus-like syndrome23.03.02.004; 15.06.02.004; 10.04.03.0030.004226%Not Available
Lymphatic disorder01.09.01.003--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Breast disorder21.05.04.004--Not Available
Connective tissue disorder10.04.04.026; 15.06.01.006--Not Available
Malnutrition14.03.02.004--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.006339%
Blood disorder01.05.01.004--Not Available
Psychotic disorder19.03.01.002--
Bone marrow failure01.03.03.005--
Drug reaction with eosinophilia and systemic symptoms12.03.01.064; 23.03.05.005; 10.01.01.0210.016903%Not Available
Lymphadenopathy mediastinal22.09.03.006; 01.09.01.0250.004226%Not Available
Benign rolandic epilepsy19.21.02.008; 17.12.03.0210.006339%Not Available
Immune thrombocytopenia01.08.01.013; 10.02.01.0830.008452%Not Available
Therapeutic product effect incomplete08.06.01.0520.009297%Not Available
Treatment noncompliance12.09.02.006; 08.06.01.0670.008452%Not Available
The 4th Page    First    Pre   4    Total 4 Pages